Free Trial

Franklin Covey (FC) Financials

Franklin Covey logo
$20.79 +0.46 (+2.28%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$20.80 +0.00 (+0.00%)
As of 04/15/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Franklin Covey

Annual Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
17 17 24
Consolidated Net Income / (Loss)
18 18 23
Net Income / (Loss) Continuing Operations
18 18 23
Total Pre-Tax Income
22 26 33
Total Operating Income
24 26 33
Total Gross Profit
202 213 221
Total Revenue
263 281 287
Operating Revenue
263 281 287
Total Cost of Revenue
61 67 66
Operating Cost of Revenue
61 67 66
Total Operating Expenses
178 187 188
Selling, General & Admin Expense
168 178 176
Depreciation Expense
4.90 4.27 3.91
Amortization Expense
5.27 4.34 4.25
Impairment Charge
0.00 0.00 0.93
Restructuring Charge
0.00 0.57 3.01
Total Other Income / (Expense), net
-1.61 -0.49 0.00
Interest Expense
1.68 1.58 1.12
Interest & Investment Income
0.07 1.09 1.12
Income Tax Expense
3.63 8.09 9.64
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
1.25 0.45 -0.22
Basic Earnings per Share
$1.30 $1.30 $1.78
Weighted Average Basic Shares Outstanding
14.15M 13.64M 13.17M
Diluted Earnings per Share
$1.27 $1.24 $1.74
Weighted Average Diluted Shares Outstanding
14.56M 14.30M 13.47M
Weighted Average Basic & Diluted Shares Outstanding
13.90M 13.43M 13.18M

Quarterly Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Income / (Loss) Attributable to Common Shareholders
7.16 4.33 4.54 1.89 4.42 6.49 4.90 0.74 5.55 12 0.98
Consolidated Net Income / (Loss)
7.16 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18
Net Income / (Loss) Continuing Operations
7.16 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18
Total Pre-Tax Income
5.57 8.28 6.06 2.78 6.58 10 5.28 1.42 8.36 18 1.59
Total Operating Income
5.95 8.66 6.39 2.83 6.57 11 5.33 1.44 8.34 18 1.48
Total Gross Profit
51 59 53 47 54 59 52 47 56 66 53
Total Revenue
66 79 69 62 71 78 68 61 73 84 69
Operating Revenue
66 79 69 62 71 78 68 61 73 84 69
Total Cost of Revenue
15 20 17 15 17 19 16 14 17 18 16
Operating Cost of Revenue
15 20 17 15 17 19 16 14 17 18 16
Total Operating Expenses
45 50 46 44 48 49 47 45 48 48 51
Selling, General & Admin Expense
43 48 44 42 46 46 44 41 45 45 47
Depreciation Expense
1.22 1.22 1.25 0.95 0.93 1.14 1.09 0.91 0.99 0.91 0.95
Amortization Expense
1.33 1.16 1.09 1.09 1.09 1.07 1.07 1.07 1.06 1.04 1.10
Restructuring Charge
- - - 0.00 0.00 - 0.58 1.73 0.70 - 1.98
Total Other Income / (Expense), net
-0.38 -0.38 -0.33 -0.05 0.01 -0.12 -0.05 -0.03 0.02 0.06 0.11
Interest Expense
0.41 0.40 0.41 0.41 0.35 0.41 0.34 0.33 0.25 0.20 0.18
Interest & Investment Income
0.02 0.02 0.08 0.36 0.36 0.29 0.29 0.30 0.27 0.27 0.29
Income Tax Expense
-1.60 2.70 1.40 1.04 2.02 3.63 0.43 0.54 2.64 6.04 0.41
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - 0.13 -0.15 0.14 0.32 -0.05 0.14 0.18 -0.48 0.20
Basic Earnings per Share
$0.51 $0.39 $0.34 $0.13 $0.33 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09
Weighted Average Basic Shares Outstanding
14.17M 14.15M 13.88M 13.90M 13.62M 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M
Diluted Earnings per Share
$0.51 $0.36 $0.32 $0.12 $0.32 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09
Weighted Average Diluted Shares Outstanding
14.18M 14.56M 14.51M 14.53M 14.27M 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M
Weighted Average Basic & Diluted Shares Outstanding
13.86M 13.90M 13.91M 13.85M 13.20M 13.43M 13.29M 13.27M 13.09M 13.18M 13.20M

Annual Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
13 -22 10
Net Cash From Operating Activities
52 36 60
Net Cash From Continuing Operating Activities
52 36 60
Net Income / (Loss) Continuing Operations
18 18 23
Consolidated Net Income / (Loss)
18 18 23
Depreciation Expense
10 8.61 8.15
Amortization Expense
4.27 3.92 3.93
Non-Cash Adjustments To Reconcile Net Income
8.29 13 11
Changes in Operating Assets and Liabilities, net
11 -7.09 14
Net Cash From Investing Activities
-5.33 -14 -11
Net Cash From Continuing Investing Activities
-5.33 -14 -11
Purchase of Property, Plant & Equipment
-3.18 -4.52 -3.69
Acquisitions
0.00 0.00 -0.75
Other Investing Activities, net
-2.15 -9.04 -6.87
Net Cash From Financing Activities
-33 -44 -39
Net Cash From Continuing Financing Activities
-33 -44 -39
Repayment of Debt
-8.72 -17 -9.37
Repurchase of Common Equity
-24 -36 -31
Issuance of Debt
0.00 7.50 0.00
Issuance of Common Equity
1.34 1.54 1.47
Other Financing Activities, net
-1.43 -0.74 0.00
Effect of Exchange Rate Changes
- -0.30 0.14
Cash Interest Paid
1.66 1.50 1.11
Cash Income Taxes Paid
3.21 3.31 4.21

Quarterly Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Net Change in Cash & Equivalents
-8.99 8.45 -2.37 -3.03 -16 -1.10 -4.27 6.95 -4.33 12 4.63
Net Cash From Operating Activities
16 13 3.02 8.19 15 9.79 17 13 8.17 22 14
Net Cash From Continuing Operating Activities
16 13 3.02 8.19 15 9.79 17 13 8.17 22 14
Net Income / (Loss) Continuing Operations
7.16 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18
Consolidated Net Income / (Loss)
7.16 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18
Depreciation Expense
2.55 2.38 2.34 2.04 2.02 2.21 2.16 1.98 2.05 1.96 2.05
Amortization Expense
0.97 1.20 1.05 1.01 0.96 0.90 0.89 1.01 1.03 1.00 1.20
Non-Cash Adjustments To Reconcile Net Income
2.37 2.30 2.74 3.32 3.31 3.16 2.90 2.30 2.83 3.05 2.17
Changes in Operating Assets and Liabilities, net
3.25 1.27 -7.77 0.08 3.89 -3.30 6.64 6.61 -3.46 3.92 7.55
Net Cash From Investing Activities
-1.42 -1.87 -2.21 -5.71 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -2.75
Net Cash From Continuing Investing Activities
-1.42 -1.87 -2.21 -5.71 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -2.75
Purchase of Property, Plant & Equipment
-0.82 -1.10 -1.24 -1.40 -0.90 -0.97 -1.07 -0.64 -0.90 -1.08 -1.00
Acquisitions
- - - - - - 0.00 - - - -0.32
Other Investing Activities, net
-0.61 -0.78 -0.97 -4.30 -1.56 -2.19 -2.67 -1.10 -1.43 -1.67 -1.43
Net Cash From Financing Activities
-23 -2.01 -2.92 -5.80 -28 -7.59 -18 -3.90 -10 -6.69 -6.58
Net Cash From Continuing Financing Activities
-23 -2.01 -2.92 -5.80 -28 -7.59 -18 -3.90 -10 -6.69 -6.58
Repayment of Debt
-2.81 -2.00 -2.02 -2.04 -11 -2.08 -2.11 -2.12 -2.98 -2.17 -0.95
Repurchase of Common Equity
-20 - -0.84 -3.83 -25 -5.88 -16 -2.11 -7.43 -4.91 -5.95
Issuance of Common Equity
0.34 0.33 0.37 0.37 0.42 0.38 0.36 0.33 0.39 0.39 0.32
Effect of Exchange Rate Changes
-0.66 - - - - -0.14 0.09 -0.18 -0.16 0.40 -0.18
Cash Interest Paid
0.51 0.36 0.37 0.37 0.42 0.34 0.34 0.28 0.32 0.18 0.14
Cash Income Taxes Paid
0.44 1.47 0.84 0.77 0.85 0.86 0.82 0.82 1.32 1.24 0.75

Annual Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
259 246 262
Total Current Assets
156 145 160
Cash & Equivalents
61 38 49
Accounts Receivable
73 82 86
Inventories, net
3.53 4.21 4.00
Prepaid Expenses
4.71 4.40 22
Plant, Property, & Equipment, net
9.80 10 8.74
Total Noncurrent Assets
93 91 93
Goodwill
31 31 31
Intangible Assets
45 41 38
Noncurrent Deferred & Refundable Income Taxes
4.69 1.66 0.87
Other Noncurrent Operating Assets
13 17 23
Total Liabilities & Shareholders' Equity
259 246 262
Total Liabilities
176 167 178
Total Current Liabilities
154 152 162
Short-Term Debt
5.84 5.84 0.84
Accounts Payable
11 6.50 7.86
Accrued Expenses
34 28 32
Customer Deposits
- 12 17
Current Deferred Revenue
86 95 101
Other Current Liabilities
17 3.54 3.11
Total Noncurrent Liabilities
23 16 16
Long-Term Debt
7.27 1.54 0.78
Noncurrent Deferred & Payable Income Tax Liabilities
0.20 2.04 3.13
Other Noncurrent Operating Liabilities
15 12 12
Total Equity & Noncontrolling Interests
83 79 83
Total Preferred & Common Equity
83 79 83
Total Common Equity
83 79 83
Common Stock
222 234 233
Retained Earnings
82 100 123
Treasury Stock
-220 -254 -272
Accumulated Other Comprehensive Income / (Loss)
-0.54 -0.99 -0.77

Quarterly Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Total Assets
228 237 234 218 219 222 221 240
Total Current Assets
122 136 131 117 117 122 120 139
Cash & Equivalents
52 58 55 39 34 41 37 53
Accounts Receivable
50 57 54 55 60 57 60 61
Inventories, net
3.36 3.48 3.47 4.57 4.12 4.20 4.64 3.83
Prepaid Expenses
16 17 19 17 19 20 18 20
Plant, Property, & Equipment, net
9.59 9.47 9.85 9.70 9.52 8.71 8.63 8.73
Total Noncurrent Assets
97 92 93 91 92 91 92 92
Goodwill
31 31 31 31 31 31 31 31
Intangible Assets
46 44 43 42 39 38 39 37
Noncurrent Deferred & Refundable Income Taxes
6.27 4.28 3.56 2.27 1.68 1.66 1.64 0.83
Other Noncurrent Operating Assets
13 12 16 16 20 20 21 23
Total Liabilities & Shareholders' Equity
228 237 234 218 219 222 221 240
Total Liabilities
153 148 143 143 148 151 149 159
Total Current Liabilities
129 128 125 128 135 138 137 144
Short-Term Debt
5.84 5.84 5.84 5.84 4.59 3.34 2.09 0.84
Accounts Payable
8.07 6.88 8.49 7.10 5.67 7.73 6.19 5.96
Accrued Expenses
29 23 19 24 21 19 22 24
Customer Deposits
- - - - - - 22 22
Current Deferred Revenue
67 74 74 70 83 82 80 89
Other Current Liabilities
20 17 18 21 20 26 3.81 2.17
Total Noncurrent Liabilities
25 20 18 15 14 13 12 16
Long-Term Debt
8.49 6.05 4.82 2.76 1.56 1.58 0.76 0.79
Noncurrent Deferred & Payable Income Tax Liabilities
0.38 0.20 0.20 0.20 1.01 1.06 1.85 2.91
Other Noncurrent Operating Liabilities
16 14 13 12 11 10 9.61 12
Total Equity & Noncontrolling Interests
75 90 91 75 71 71 72 81
Total Preferred & Common Equity
75 90 91 75 71 71 72 81
Total Common Equity
75 90 91 75 71 71 72 81
Common Stock
219 224 227 230 226 227 230 229
Retained Earnings
76 87 88 93 105 106 111 124
Treasury Stock
-221 -220 -224 -248 -259 -261 -268 -271
Accumulated Other Comprehensive Income / (Loss)
-0.20 -0.67 -0.53 -0.67 -0.94 -1.08 -1.25 -0.97

Annual Metrics and Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
17.25% 6.73% 2.39%
EBITDA Growth
60.50% 2.05% 16.03%
EBIT Growth
192.24% 11.35% 25.34%
NOPAT Growth
8.85% -8.37% 29.14%
Net Income Growth
35.29% -3.52% 31.61%
EPS Growth
32.29% -2.36% 40.32%
Operating Cash Flow Growth
13.16% -31.61% 68.61%
Free Cash Flow Firm Growth
85.32% -83.93% 513.28%
Invested Capital Growth
-30.93% 35.01% -24.51%
Revenue Q/Q Growth
3.90% -0.30% 2.20%
EBITDA Q/Q Growth
11.83% 3.85% 18.98%
EBIT Q/Q Growth
22.52% 7.79% 28.65%
NOPAT Q/Q Growth
23.21% 6.13% 27.25%
Net Income Q/Q Growth
25.72% 7.46% 28.17%
EPS Q/Q Growth
23.30% 10.71% 30.83%
Operating Cash Flow Q/Q Growth
-4.75% -7.57% 25.08%
Free Cash Flow Firm Q/Q Growth
-31.71% -45.46% 47.95%
Invested Capital Q/Q Growth
-4.85% 9.18% -6.12%
Profitability Metrics
- - -
Gross Margin
76.82% 76.10% 76.97%
EBITDA Margin
14.50% 13.86% 15.71%
Operating Margin
9.01% 9.40% 11.50%
EBIT Margin
9.01% 9.40% 11.50%
Profit (Net Income) Margin
7.01% 6.34% 8.15%
Tax Burden Percent
83.53% 68.73% 70.82%
Interest Burden Percent
93.20% 98.13% 100.01%
Effective Tax Rate
16.47% 31.27% 29.18%
Return on Invested Capital (ROIC)
45.64% 43.56% 55.79%
ROIC Less NNEP Spread (ROIC-NNEP)
49.18% 44.42% 55.79%
Return on Net Nonoperating Assets (RNNOA)
-22.98% -21.53% -26.87%
Return on Equity (ROE)
22.66% 22.02% 28.93%
Cash Return on Invested Capital (CROIC)
82.24% 13.76% 83.72%
Operating Return on Assets (OROA)
9.31% 10.44% 13.02%
Return on Assets (ROA)
7.24% 7.04% 9.22%
Return on Common Equity (ROCE)
22.66% 22.02% 28.93%
Return on Equity Simple (ROE_SIMPLE)
22.25% 22.61% 28.15%
Net Operating Profit after Tax (NOPAT)
20 18 23
NOPAT Margin
7.52% 6.46% 8.15%
Net Nonoperating Expense Percent (NNEP)
-3.54% -0.86% 0.01%
Cost of Revenue to Revenue
23.18% 23.90% 23.03%
SG&A Expenses to Revenue
63.94% 63.44% 61.25%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
67.81% 66.71% 65.46%
Earnings before Interest and Taxes (EBIT)
24 26 33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
38 39 45
Valuation Ratios
- - -
Price to Book Value (P/BV)
7.96 7.16 6.34
Price to Tangible Book Value (P/TBV)
97.51 81.39 37.26
Price to Revenue (P/Rev)
2.51 2.01 1.84
Price to Earnings (P/E)
38.37 32.50 22.32
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
2.61% 3.08% 4.48%
Enterprise Value to Invested Capital (EV/IC)
17.28 11.14 13.31
Enterprise Value to Revenue (EV/Rev)
2.33 1.90 1.67
Enterprise Value to EBITDA (EV/EBITDA)
16.05 13.69 10.64
Enterprise Value to EBIT (EV/EBIT)
25.84 20.20 14.53
Enterprise Value to NOPAT (EV/NOPAT)
30.94 29.39 20.52
Enterprise Value to Operating Cash Flow (EV/OCF)
11.71 14.90 7.97
Enterprise Value to Free Cash Flow (EV/FCFF)
17.17 93.02 13.67
Leverage & Solvency
- - -
Debt to Equity
0.16 0.09 0.02
Long-Term Debt to Equity
0.09 0.02 0.01
Financial Leverage
-0.47 -0.48 -0.48
Leverage Ratio
3.13 3.13 3.14
Compound Leverage Factor
2.92 3.07 3.14
Debt to Total Capital
13.66% 8.57% 1.90%
Short-Term Debt to Total Capital
6.08% 6.78% 0.99%
Long-Term Debt to Total Capital
7.58% 1.78% 0.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
86.34% 91.43% 98.10%
Debt to EBITDA
0.34 0.19 0.04
Net Debt to EBITDA
-1.24 -0.79 -1.04
Long-Term Debt to EBITDA
0.19 0.04 0.02
Debt to NOPAT
0.66 0.41 0.07
Net Debt to NOPAT
-2.40 -1.70 -2.01
Long-Term Debt to NOPAT
0.37 0.08 0.03
Altman Z-Score
4.01 4.05 3.94
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
1.01 0.96 0.99
Quick Ratio
0.87 0.79 0.83
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
36 5.73 35
Operating Cash Flow to CapEx
1,644.76% 791.54% 1,631.21%
Free Cash Flow to Firm to Interest Expense
21.27 3.62 31.38
Operating Cash Flow to Interest Expense
31.20 22.58 53.85
Operating Cash Flow Less CapEx to Interest Expense
29.30 19.72 50.55
Efficiency Ratios
- - -
Asset Turnover
1.03 1.11 1.13
Accounts Receivable Turnover
3.67 3.63 3.42
Inventory Turnover
20.23 17.32 16.11
Fixed Asset Turnover
24.65 28.28 30.60
Accounts Payable Turnover
6.84 7.72 9.21
Days Sales Outstanding (DSO)
99.46 100.51 106.70
Days Inventory Outstanding (DIO)
18.04 21.07 22.66
Days Payable Outstanding (DPO)
53.35 47.28 39.62
Cash Conversion Cycle (CCC)
64.15 74.31 89.74
Capital & Investment Metrics
- - -
Invested Capital
35 48 36
Invested Capital Turnover
6.07 6.74 6.85
Increase / (Decrease) in Invested Capital
-16 12 -12
Enterprise Value (EV)
612 533 480
Market Capitalization
659 563 527
Book Value per Share
$5.98 $5.96 $6.35
Tangible Book Value per Share
$0.49 $0.52 $1.08
Total Capital
96 86 85
Total Debt
13 7.37 1.61
Total Long-Term Debt
7.27 1.54 0.78
Net Debt
-47 -31 -47
Capital Expenditures (CapEx)
3.18 4.52 3.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-53 -39 -50
Debt-free Net Working Capital (DFNWC)
7.92 -0.80 -1.37
Net Working Capital (NWC)
2.09 -6.63 -2.20
Net Nonoperating Expense (NNE)
1.34 0.34 -0.00
Net Nonoperating Obligations (NNO)
-47 -31 -47
Total Depreciation and Amortization (D&A)
14 13 12
Debt-free, Cash-free Net Working Capital to Revenue
-20.01% -13.91% -17.42%
Debt-free Net Working Capital to Revenue
3.01% -0.28% -0.48%
Net Working Capital to Revenue
0.79% -2.36% -0.77%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$1.30 $1.30 $1.78
Adjusted Weighted Average Basic Shares Outstanding
14.15M 13.64M 13.17M
Adjusted Diluted Earnings per Share
$1.27 $1.24 $1.74
Adjusted Weighted Average Diluted Shares Outstanding
14.56M 14.30M 13.47M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.90M 13.43M 13.18M
Normalized Net Operating Profit after Tax (NOPAT)
20 19 26
Normalized NOPAT Margin
7.52% 6.60% 9.12%
Pre Tax Income Margin
8.39% 9.22% 11.50%
Debt Service Ratios
- - -
EBIT to Interest Expense
14.13 16.65 29.53
NOPAT to Interest Expense
11.81 11.45 20.91
EBIT Less CapEx to Interest Expense
12.24 13.80 26.23
NOPAT Less CapEx to Interest Expense
9.91 8.59 17.61
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
129.41% 199.96% 131.39%

Quarterly Metrics and Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
12.67% 14.30% 13.24% 9.11% 7.96% -1.08% -1.40% -0.68% 2.70% 7.91% 1.00%
EBITDA Growth
38.09% 49.10% 5.47% -17.52% 0.87% 11.79% -14.27% -24.54% 19.64% 52.61% -43.71%
EBIT Growth
91.04% 100.90% 15.28% -19.59% 10.47% 22.00% -16.63% -49.01% 26.95% 69.63% -72.32%
NOPAT Growth
-49.78% 189.37% 19.04% -16.84% -40.47% 18.09% -0.42% -49.63% 25.22% 72.85% -77.60%
Net Income Growth
-43.85% 208.69% 22.43% -7.40% -36.29% 22.12% 3.94% -49.74% 25.38% 75.51% -75.65%
EPS Growth
-43.33% 200.00% 18.52% -7.69% -37.25% 33.33% 12.50% -50.00% 34.38% 85.42% -75.00%
Operating Cash Flow Growth
82.30% -17.01% -70.32% -37.35% -9.57% -23.01% 477.99% 55.95% -44.55% 123.39% -18.88%
Free Cash Flow Firm Growth
185.42% 604.99% -33.70% -130.07% -104.61% -125.36% -44.12% 451.47% 647.90% 529.48% 166.12%
Invested Capital Growth
-49.26% -30.93% -10.41% 13.16% 17.67% 35.01% -1.53% -25.72% -12.20% -24.51% -32.11%
Revenue Q/Q Growth
16.92% 19.09% -11.98% -10.97% 15.68% 9.12% -12.26% -10.33% 19.62% 14.65% -17.88%
EBITDA Q/Q Growth
32.73% 29.24% -20.12% -39.81% 62.32% 43.24% -38.74% -47.02% 157.36% 82.72% -77.40%
EBIT Q/Q Growth
69.15% 45.62% -26.21% -55.76% 132.39% 60.82% -49.58% -72.94% 478.57% 114.89% -91.77%
NOPAT Q/Q Growth
260.04% -23.76% -15.70% -64.06% 157.72% 51.24% -28.92% -81.82% 540.71% 108.78% -90.79%
Net Income Q/Q Growth
281.36% -22.12% -16.33% -62.74% 162.39% 49.29% -28.79% -81.98% 554.58% 108.98% -90.12%
EPS Q/Q Growth
292.31% -29.41% -11.11% -62.50% 166.67% 50.00% -25.00% -83.33% 616.67% 106.98% -89.89%
Operating Cash Flow Q/Q Growth
24.66% -21.97% -76.28% 171.49% 79.94% -33.57% 78.10% -26.75% -36.02% 167.61% -35.33%
Free Cash Flow Firm Q/Q Growth
257.14% -50.45% -54.11% -137.02% 45.29% -172.80% 201.12% 132.87% -14.71% 113.84% -37.34%
Invested Capital Q/Q Growth
-10.23% -4.85% 22.45% 8.19% -6.65% 9.18% -10.69% -18.39% 10.33% -6.12% -19.69%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
77.27% 74.95% 76.03% 76.45% 75.91% 76.08% 76.43% 76.38% 76.60% 78.14% 76.30%
EBITDA Margin
14.31% 15.53% 14.09% 9.53% 13.37% 17.55% 12.25% 7.24% 15.57% 24.82% 6.83%
Operating Margin
8.99% 10.99% 9.21% 4.58% 9.20% 13.56% 7.79% 2.35% 11.37% 21.31% 2.14%
EBIT Margin
8.99% 10.99% 9.21% 4.58% 9.20% 13.56% 7.79% 2.35% 11.37% 21.31% 2.14%
Profit (Net Income) Margin
10.82% 7.08% 6.73% 2.82% 6.39% 8.74% 7.09% 1.42% 7.80% 14.21% 1.71%
Tax Burden Percent
128.70% 67.38% 76.98% 62.53% 69.35% 65.22% 91.94% 61.77% 68.40% 66.46% 74.42%
Interest Burden Percent
93.55% 95.57% 94.85% 98.34% 100.12% 98.83% 99.01% 98.13% 100.25% 100.35% 107.59%
Effective Tax Rate
-28.70% 32.62% 23.02% 37.47% 30.65% 34.78% 8.06% 38.23% 31.60% 33.54% 25.58%
Return on Invested Capital (ROIC)
52.96% 44.93% 41.90% 17.90% 44.33% 59.63% 46.56% 9.92% 53.18% 97.00% 12.77%
ROIC Less NNEP Spread (ROIC-NNEP)
55.51% 45.61% 42.54% 17.97% 44.32% 59.84% 46.69% 9.96% 53.13% 96.89% 12.56%
Return on Net Nonoperating Assets (RNNOA)
-14.41% -21.31% -19.81% -9.02% -20.30% -29.01% -21.60% -4.94% -23.35% -46.66% -6.60%
Return on Equity (ROE)
38.55% 23.62% 22.10% 8.88% 24.03% 30.62% 24.95% 4.98% 29.83% 50.34% 6.16%
Cash Return on Invested Capital (CROIC)
94.41% 82.24% 55.78% 33.18% 25.93% 13.76% 43.67% 71.71% 57.73% 83.72% 93.01%
Operating Return on Assets (OROA)
10.31% 11.36% 10.67% 5.41% 11.60% 15.06% 9.55% 2.88% 14.57% 24.13% 2.68%
Return on Assets (ROA)
12.42% 7.31% 7.79% 3.33% 8.06% 9.71% 8.69% 1.74% 9.99% 16.09% 2.15%
Return on Common Equity (ROCE)
38.55% 23.62% 22.10% 8.88% 24.03% 30.62% 24.95% 4.98% 29.83% 50.34% 6.16%
Return on Equity Simple (ROE_SIMPLE)
19.56% 0.00% 21.52% 20.96% 22.21% 0.00% 25.48% 24.14% 25.30% 0.00% 24.47%
Net Operating Profit after Tax (NOPAT)
7.66 5.84 4.92 1.77 4.56 6.89 4.90 0.89 5.71 12 1.10
NOPAT Margin
11.57% 7.41% 7.09% 2.86% 6.38% 8.84% 7.16% 1.45% 7.78% 14.16% 1.59%
Net Nonoperating Expense Percent (NNEP)
-2.55% -0.68% -0.63% -0.07% 0.02% -0.21% -0.13% -0.04% 0.04% 0.11% 0.21%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 6.39% - - - 1.33%
Cost of Revenue to Revenue
22.73% 25.05% 23.97% 23.55% 24.09% 23.92% 23.57% 23.62% 23.40% 21.86% 23.70%
SG&A Expenses to Revenue
64.43% 60.94% 63.45% 68.56% 63.89% 58.96% 64.63% 66.47% 61.48% 53.82% 68.33%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
68.28% 63.96% 66.82% 71.87% 66.71% 62.52% 68.64% 74.03% 65.23% 56.83% 74.16%
Earnings before Interest and Taxes (EBIT)
5.95 8.66 6.39 2.83 6.57 11 5.33 1.44 8.34 18 1.48
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
9.47 12 9.78 5.88 9.55 14 8.38 4.44 11 21 4.72
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.33 7.96 8.06 7.13 6.86 7.16 7.41 7.16 6.80 6.34 5.95
Price to Tangible Book Value (P/TBV)
0.00 97.51 49.27 37.26 299.97 81.39 0.00 410.41 229.90 37.26 39.11
Price to Revenue (P/Rev)
2.17 2.51 2.66 2.36 1.82 2.01 1.87 1.82 1.75 1.84 1.67
Price to Earnings (P/E)
37.31 38.37 40.33 36.39 33.71 32.50 29.51 30.65 27.77 22.32 24.35
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.68% 2.61% 2.48% 2.75% 2.97% 3.08% 3.39% 3.26% 3.60% 4.48% 4.11%
Enterprise Value to Invested Capital (EV/IC)
13.76 17.28 15.59 12.95 10.98 11.14 11.58 13.53 11.89 13.31 14.77
Enterprise Value to Revenue (EV/Rev)
2.02 2.33 2.49 2.20 1.71 1.90 1.77 1.69 1.63 1.67 1.49
Enterprise Value to EBITDA (EV/EBITDA)
15.02 16.05 17.50 16.25 12.84 13.69 13.19 13.07 12.05 10.64 10.32
Enterprise Value to EBIT (EV/EBIT)
26.48 25.84 27.56 25.48 19.66 20.20 19.55 19.71 17.80 14.53 14.66
Enterprise Value to NOPAT (EV/NOPAT)
31.88 30.94 32.89 30.20 28.16 29.39 27.29 27.33 24.86 20.52 21.81
Enterprise Value to Operating Cash Flow (EV/OCF)
9.33 11.71 14.98 15.10 12.43 14.90 9.86 8.61 9.49 7.97 7.51
Enterprise Value to Free Cash Flow (EV/FCFF)
9.81 17.17 26.41 41.43 45.79 93.02 26.33 16.08 19.26 13.67 12.84
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.19 0.16 0.13 0.12 0.12 0.09 0.09 0.07 0.04 0.02 0.02
Long-Term Debt to Equity
0.11 0.09 0.07 0.05 0.04 0.02 0.02 0.02 0.01 0.01 0.01
Financial Leverage
-0.26 -0.47 -0.47 -0.50 -0.46 -0.48 -0.46 -0.50 -0.44 -0.48 -0.53
Leverage Ratio
2.95 3.13 2.73 2.63 2.99 3.13 2.85 2.81 2.99 3.14 3.04
Compound Leverage Factor
2.76 2.99 2.59 2.59 2.99 3.09 2.82 2.76 3.00 3.15 3.27
Debt to Total Capital
16.05% 13.66% 11.70% 10.45% 10.35% 8.57% 8.01% 6.49% 3.79% 1.90% 1.97%
Short-Term Debt to Total Capital
6.54% 6.08% 5.75% 5.72% 7.02% 6.78% 5.98% 4.40% 2.78% 0.99% 1.01%
Long-Term Debt to Total Capital
9.51% 7.58% 5.96% 4.73% 3.33% 1.78% 2.03% 2.08% 1.01% 0.91% 0.96%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
83.95% 86.34% 88.30% 89.55% 89.65% 91.43% 91.99% 93.51% 96.21% 98.10% 98.03%
Debt to EBITDA
0.42 0.34 0.31 0.29 0.23 0.19 0.16 0.14 0.08 0.04 0.04
Net Debt to EBITDA
-1.11 -1.24 -1.20 -1.19 -0.82 -0.79 -0.74 -1.00 -0.89 -1.04 -1.25
Long-Term Debt to EBITDA
0.25 0.19 0.16 0.13 0.07 0.04 0.04 0.04 0.02 0.02 0.02
Debt to NOPAT
0.89 0.66 0.58 0.53 0.50 0.41 0.34 0.28 0.15 0.07 0.08
Net Debt to NOPAT
-2.35 -2.40 -2.25 -2.21 -1.80 -1.70 -1.54 -2.09 -1.83 -2.01 -2.63
Long-Term Debt to NOPAT
0.53 0.37 0.29 0.24 0.16 0.08 0.09 0.09 0.04 0.03 0.04
Altman Z-Score
3.77 3.82 4.72 4.52 4.07 3.84 4.04 3.87 3.99 3.75 3.73
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.95 1.01 1.07 1.05 0.91 0.96 0.87 0.88 0.88 0.99 0.97
Quick Ratio
0.80 0.87 0.90 0.87 0.74 0.79 0.70 0.71 0.71 0.83 0.80
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
44 22 9.96 -3.69 -2.02 -5.50 5.56 13 11 24 15
Operating Cash Flow to CapEx
1,997.30% 1,159.34% 243.31% 583.40% 1,635.85% 1,009.38% 1,626.68% 1,983.54% 906.10% 2,032.71% 1,417.33%
Free Cash Flow to Firm to Interest Expense
108.10 54.10 24.28 -9.01 -5.70 -13.42 16.31 39.49 44.73 116.38 83.17
Operating Cash Flow to Interest Expense
40.24 31.72 7.36 20.03 41.64 23.88 51.14 38.95 33.09 107.74 79.47
Operating Cash Flow Less CapEx to Interest Expense
38.23 28.98 4.33 16.59 39.09 21.51 47.99 36.98 29.44 102.44 73.86
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.15 1.03 1.16 1.18 1.26 1.11 1.23 1.22 1.28 1.13 1.26
Accounts Receivable Turnover
5.33 3.67 4.97 5.44 5.31 3.63 4.77 5.03 4.85 3.42 4.75
Inventory Turnover
18.93 20.23 21.10 22.21 17.18 17.32 17.52 17.34 14.41 16.11 16.72
Fixed Asset Turnover
23.31 24.65 27.03 27.77 29.17 28.28 29.45 30.08 30.67 30.60 31.55
Accounts Payable Turnover
8.94 6.84 10.34 8.72 8.98 7.72 10.61 8.19 10.00 9.21 11.42
Days Sales Outstanding (DSO)
68.47 99.46 73.45 67.06 68.69 100.51 76.52 72.50 75.26 106.70 76.87
Days Inventory Outstanding (DIO)
19.28 18.04 17.30 16.44 21.24 21.07 20.83 21.04 25.32 22.66 21.83
Days Payable Outstanding (DPO)
40.83 53.35 35.31 41.87 40.64 47.28 34.41 44.54 36.51 39.62 31.95
Cash Conversion Cycle (CCC)
46.92 64.15 55.43 41.62 49.29 74.31 62.94 49.00 64.07 89.74 66.75
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
37 35 43 47 44 48 43 35 38 36 29
Invested Capital Turnover
4.58 6.07 5.91 6.25 6.95 6.74 6.50 6.83 6.84 6.85 8.04
Increase / (Decrease) in Invested Capital
-36 -16 -5.04 5.45 6.57 12 -0.66 -12 -5.34 -12 -14
Enterprise Value (EV)
512 612 676 607 481 533 494 471 457 480 428
Market Capitalization
549 659 722 652 511 563 522 507 491 527 480
Book Value per Share
$5.23 $5.98 $6.45 $6.57 $5.38 $5.96 $5.25 $5.33 $5.44 $6.35 $6.12
Tangible Book Value per Share
($0.16) $0.49 $1.05 $1.26 $0.12 $0.52 ($0.01) $0.09 $0.16 $1.08 $0.93
Total Capital
89 96 101 102 83 86 77 76 75 85 82
Total Debt
14 13 12 11 8.60 7.37 6.14 4.91 2.85 1.61 1.62
Total Long-Term Debt
8.49 7.27 6.05 4.82 2.76 1.54 1.56 1.58 0.76 0.78 0.79
Net Debt
-38 -47 -46 -44 -31 -31 -28 -36 -34 -47 -52
Capital Expenditures (CapEx)
0.82 1.10 1.24 1.40 0.90 0.97 1.07 0.64 0.90 1.08 1.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-53 -53 -44 -43 -45 -39 -47 -54 -51 -50 -57
Debt-free Net Working Capital (DFNWC)
-0.96 7.92 15 12 -5.84 -0.80 -13 -13 -14 -1.37 -3.92
Net Working Capital (NWC)
-6.80 2.09 8.67 5.80 -12 -6.63 -17 -16 -17 -2.20 -4.75
Net Nonoperating Expense (NNE)
0.49 0.26 0.25 0.03 -0.01 0.08 0.05 0.02 -0.01 -0.04 -0.08
Net Nonoperating Obligations (NNO)
-38 -47 -46 -44 -31 -31 -28 -36 -34 -47 -52
Total Depreciation and Amortization (D&A)
3.52 3.58 3.38 3.06 2.98 3.11 3.05 3.00 3.08 2.95 3.24
Debt-free, Cash-free Net Working Capital to Revenue
-20.96% -20.01% -16.11% -15.75% -16.05% -13.91% -16.75% -19.20% -18.16% -17.42% -19.87%
Debt-free Net Working Capital to Revenue
-0.38% 3.01% 5.35% 4.21% -2.08% -0.28% -4.60% -4.55% -5.15% -0.48% -1.36%
Net Working Capital to Revenue
-2.69% 0.79% 3.20% 2.10% -4.15% -2.36% -6.24% -5.74% -5.89% -0.77% -1.65%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.51 $0.39 $0.34 $0.13 $0.33 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09
Adjusted Weighted Average Basic Shares Outstanding
14.17M 14.15M 13.88M 13.90M 13.62M 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M
Adjusted Diluted Earnings per Share
$0.51 $0.36 $0.32 $0.12 $0.32 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09
Adjusted Weighted Average Diluted Shares Outstanding
14.18M 14.56M 14.51M 14.53M 14.27M 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.86M 13.90M 13.91M 13.85M 13.20M 13.43M 13.29M 13.27M 13.09M 13.18M 13.20M
Normalized Net Operating Profit after Tax (NOPAT)
4.16 5.84 4.92 1.77 4.56 6.89 5.43 2.53 6.19 12 2.57
Normalized NOPAT Margin
6.29% 7.41% 7.09% 2.86% 6.38% 8.84% 7.94% 4.12% 8.43% 14.16% 3.73%
Pre Tax Income Margin
8.41% 10.51% 8.74% 4.50% 9.21% 13.40% 7.71% 2.31% 11.40% 21.39% 2.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
14.69 21.60 15.59 6.91 18.57 25.78 15.63 4.40 33.78 88.32 8.29
NOPAT to Interest Expense
18.90 14.56 12.00 4.32 12.87 16.81 14.37 2.72 23.10 58.69 6.17
EBIT Less CapEx to Interest Expense
12.67 18.87 12.57 3.48 16.02 23.41 12.48 2.43 30.13 83.01 2.68
NOPAT Less CapEx to Interest Expense
16.89 11.82 8.98 0.89 10.33 14.45 11.23 0.75 19.45 53.39 0.56
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
162.70% 129.41% 109.91% 130.47% 179.32% 199.96% 284.04% 288.32% 173.77% 131.39% 103.36%

Frequently Asked Questions About Franklin Covey's Financials

When does Franklin Covey's financial year end?

According to the most recent income statement we have on file, Franklin Covey's fiscal year ends in August. Their fiscal year 2024 ended on August 31, 2024.

How has Franklin Covey's net income changed over the last 2 years?

Franklin Covey's net income appears to be on an upward trend, with a most recent value of $23.40 million in 2024, rising from $18.43 million in 2022. The previous period was $17.78 million in 2023.

What is Franklin Covey's operating income?
Franklin Covey's total operating income in 2024 was $33.04 million, based on the following breakdown:
  • Total Gross Profit: $221.07 million
  • Total Operating Expenses: $188.03 million
How has Franklin Covey revenue changed over the last 2 years?

Over the last 2 years, Franklin Covey's total revenue changed from $262.84 million in 2022 to $287.23 million in 2024, a change of 9.3%.

How much debt does Franklin Covey have?

Franklin Covey's total liabilities were at $178.40 million at the end of 2024, a 6.7% increase from 2023, and a 1.2% increase since 2022.

How much cash does Franklin Covey have?

In the past 2 years, Franklin Covey's cash and equivalents has ranged from $38.23 million in 2023 to $60.52 million in 2022, and is currently $48.66 million as of their latest financial filing in 2024.

How has Franklin Covey's book value per share changed over the last 2 years?

Over the last 2 years, Franklin Covey's book value per share changed from 5.98 in 2022 to 6.35 in 2024, a change of 6.2%.

Remove Ads


This page (NYSE:FC) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners